SCHEMBL8975130

SCHEMBL8975130

CC(COc1ccc(CC2SC(=O)NC2=O)cc1)NCC(O)COCc1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 12/20 0.52
PPARG P37231 7/20 0.51
PPARA Q07869 5/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8974677 0.92 PPARG (0.57) FFAR1PPARGPPARA
SCHEMBL8974550 0.91 FFAR1 (0.52) FFAR1PPARG
SCHEMBL8975268 0.90 FFAR1 (0.51) FFAR1PPARGPPARA
SCHEMBL8974649 0.90 FFAR1 (0.53) FFAR1PPARGPPARA
SCHEMBL8975029 0.90 FFAR1 (0.50) FFAR1PPARG
SCHEMBL8974734 0.89 FFAR1 (0.56) FFAR1PPARGPPARA
SCHEMBL8974598 0.89 FFAR1 (0.49) FFAR1PPARG
SCHEMBL8975051 0.88 FFAR1 (0.49) FFAR1PPARG
SCHEMBL8974931 0.88 FFAR1 (0.49) FFAR1PPARG
SCHEMBL8975311 0.88 FFAR1 (0.49) FFAR1PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5578620-A TREATMENT OF DIABETES AND HYPERLIPEMIA SANKYO COMPANY, LIMITED (JP) 1996-11-26 US disclosed
EP-0678511-A2 Thiazolidine and oxazolidine derivatives, their preparation and their medical use SANKYO COMPANY LIMITED (JP) 1995-10-25 EP disclosed